Dr. Lembke, Chief of the Stanford Addiction Medicine Dual Diagnosis Clinic, has long been one of the clearest voices regarding problems that come with over-prescribed medications and the unprecedented access to high-reward, high-dopamine stimuli in general. In this question-and-answer recording, Meadows Senior Fellow Dr. Kevin McCauley and Dr. Anna Lembke will discuss how technology, including smartphones and social media, can become “drug-ified,” as well as the difficult but effective strategies that restore the brain’s balance of pleasure and pain and allow us to rediscover passion and find new ways to be free.
| File type | File name | Number of pages | |
|---|---|---|---|
|
Transcript
(111.4 KB)
The recording audio begins on page four of the transcript file. |
22 Pages | Available after Purchase | |
| Transcript - French (111.4 KB) | 22 Pages | Available after Purchase | |
| Transcript - Italian (111.4 KB) | 22 Pages | Available after Purchase |
Dr. Anna Lembke, professor of psychiatry at Stanford University School of Medicine and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Author of Dopamine Nation: Finding Balance in the Age of Indulgence.
Speaker Disclosures:
Financial: Dr. Anna Lembke has an employment relationship with the Department of Psychiatry and Behavioral Sciences, Stanford Health Care, and Stanford University Hospital. She is a consultant in opioid litigation, and she receives royalties as a published author. Dr. Lembke receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Anna Lembke is a member of the American Society of Addiction Medicine (ASAM), the California Society of Addiction Medicine (CSAM), the American Psychiatric Association (APA), the American College of Academic Addiction Medicine (ACAAM), and the Opioid Industry Documents Archive National Advisory Committee (NAC).
Kevin McCauley, MD, is a senior fellow at Meadows Behavioral Healthcare. He first became interested in the treatment of substance use disorders while serving as a naval flight surgeon where he observed the US Navy’s policy of treating addiction as a safety (not a moral) issue, returning treated pilots to flight status under careful monitoring. Dr. McCauley wrote and directed two films: Memo to Self, exploring the concepts of recovery management, and Pleasure Unwoven, on neuroscience of addiction. He won the 2010 Michael Q. Ford Award for Journalism from the National Association of Addiction Treatment Providers.
As a person in long-term recovery himself, Dr. McCauley is grateful for the many benefits he received to establish his sobriety and strives to make sure that people have access to the same benefits and opportunities. He is committed to understanding how addiction plays out in the lives of people from diverse races and different cultures, genders, and orientations, and hearing their unique perspectives of recovery. Although addiction can be a debilitating disease personally and spiritually, Dr. McCauley joins with his colleagues to treat people seeking sobriety with respect, preserve their dignity, and accompany them as they find their own path into recovery.
Speaker Disclosures:
Financial: Kevin McCauley is the co-founder of the Institute for Addiction Study, has an employment relationship with Meadows Behavioral Healthcare, and receives a speaking honorarium from Imagine Recovery. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Kevin McCauley has no relevant non-financial relationships.
Access never expires for this product.
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
Please wait ...
